About
Contact & Profiles
A5039673989
Research Areas
- CAR-T cell therapy research
- MXene and MAX Phase Materials
- RNA Interference and Gene Delivery
Zhongshan Hospital
2023
Fudan University
2023
Intrahepatic cholangiocarcinoma (ICC) is a common malignancy arising from the liver with limited 5-year survival. Thus, there an urgency to explore new treatment methods. Chimeric antigen receptor T (CAR T) cell therapy very promising cancer treatment. Though, several groups have investigated CAR cells targeting MUC1 in solid models, Tn-MUC1-targeted not yet be reported ICC. In this study, we confirmed Tn-MUC1 as potential therapeutic target for ICC and demonstrated that its expression level...
10.1097/cji.0000000000000460
article
EN
cc-by-nc-nd
Journal of Immunotherapy
2023-03-08
Coming Soon ...